-
2
-
-
0141886220
-
IFN-α skews monocyte differentiation into toll-like receptor 7-expressing dendritic cells with potent functional activities
-
Mohty M, Vialle-Castellano A, Nunes JA, et al. IFN-alpha skews monocyte differentiation into Toll-like receptor 7-expressing dendritic cells with potent functional activities. J Immunol. 2003;171:3385-3393. (Pubitemid 37254538)
-
(2003)
Journal of Immunology
, vol.171
, Issue.7
, pp. 3385-3393
-
-
Mohty, M.1
Vialle-Castellano, A.2
Nunes, J.A.3
Isnardon, D.4
Olive, D.5
Gaugler, B.6
-
3
-
-
50649093779
-
The use of TLR7 and TLR8 ligands for the enhancement of cancer immunother-apy
-
Smits EL, Ponsaerts P, Berneman ZN, et al. The use of TLR7 and TLR8 ligands for the enhancement of cancer immunother-apy. Oncologist. 2008;13:859-875.
-
(2008)
Oncologist
, vol.13
, pp. 859-875
-
-
Smits, E.L.1
Ponsaerts, P.2
Berneman, Z.N.3
-
5
-
-
0347320541
-
Induction of apoptosis by Toll-like receptor-7 agonist in tissue cultures
-
Meyer T, Nindl I, Schmook T, et al. Induction of apoptosis by Toll-like receptor-7 agonist in tissue cultures. Br J Dermatol. 2003;149(suppl 66):9-14.
-
(2003)
Br J Dermatol
, vol.149
, Issue.SUPPL. 66
, pp. 9-14
-
-
Meyer, T.1
Nindl, I.2
Schmook, T.3
-
6
-
-
75149134844
-
More than a decade on: Review of the use of imiquimod in lower anogenital intra-epithelial neoplasia
-
Mahto M, Nathan M, O'Mahony C. More than a decade on: review of the use of imiquimod in lower anogenital intra-epithelial neoplasia. Int J STD AIDS. 2010;21:8-16.
-
(2010)
Int J STD AIDS
, vol.21
, pp. 8-16
-
-
Mahto, M.1
Nathan, M.2
O'Mahony, C.3
-
7
-
-
66949170320
-
Locally administered TLR7 agonists drive systemic antitumor immune responses that are enhanced by anti-CD40 immunotherapy
-
Broomfield SA, van der Most RG, Prosser AC, et al. Locally administered TLR7 agonists drive systemic antitumor immune responses that are enhanced by anti-CD40 immunotherapy. J Immunol. 2009;182:5217-5224.
-
(2009)
J Immunol
, vol.182
, pp. 5217-5224
-
-
Broomfield, S.A.1
Van Der Most, R.G.2
Prosser, A.C.3
-
8
-
-
29644446061
-
The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: Relation to central nervous system antitumor immunity
-
Prins RM, Craft N, Bruhn KW, et al. The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunity. J Immunol. 2006;176: 157-164. (Pubitemid 43023259)
-
(2006)
Journal of Immunology
, vol.176
, Issue.1
, pp. 157-164
-
-
Prins, R.M.1
Craft, N.2
Bruhn, K.W.3
Khan-Farooqi, H.4
Koya, R.C.5
Stripecke, R.6
Miller, J.F.7
Liau, L.M.8
-
9
-
-
34249056542
-
Transposon-based interferon gamma gene transfer overcomes limitations of episomal plasmid for immunogene therapy of glioblastoma
-
DOI 10.1038/sj.cgt.7701045, PII 7701045
-
Wu A, Oh S, Ericson K, et al. Transposon-based interferon gamma gene transfer overcomes limitations of episomal plasmid for immunogene therapy of glioblastoma. Cancer Gene Ther. 2007;14:550-560. (Pubitemid 46788330)
-
(2007)
Cancer Gene Therapy
, vol.14
, Issue.6
, pp. 550-560
-
-
Wu, A.1
Oh, S.2
Ericson, K.3
Demorest, Z.L.4
Vengco, I.5
Gharagozlou, S.6
Chen, W.7
Low, W.C.8
Ohlfest, J.R.9
-
10
-
-
27744497800
-
Combinatorial antiangiogenic gene therapy by nonviral gene transfer using the Sleeping Beauty transposon causes tumor regression and improves survival in mice bearing intracranial human glioblastoma
-
DOI 10.1016/j.ymthe.2005.07.689, PII S1525001605014292
-
Ohlfest JR, Demorest ZL, Motooka Y, et al. Combinatorial antiangiogenic gene therapy by nonviral gene transfer using the sleeping beauty transposon causes tumor regression and improves survival in mice bearing intracranial human glio-blastoma. Mol Ther. 2005;12:778-788. (Pubitemid 41614473)
-
(2005)
Molecular Therapy
, vol.12
, Issue.5
, pp. 778-788
-
-
Ohlfest, J.R.1
Demorest, Z.L.2
Motooka, Y.3
Vengco, I.4
Oh, S.5
Chen, E.6
Scappaticci, F.A.7
Saplis, R.J.8
Ekker, S.C.9
Low, W.C.10
Freese, A.B.11
Largaespada, D.A.12
-
11
-
-
53049095387
-
Effective CpG immunotherapy of breast carcinoma prevents but fails to eradicate established brain metastasis
-
Xiong Z, Gharagozlou S, Vengco I, et al. Effective CpG immunotherapy of breast carcinoma prevents but fails to eradicate established brain metastasis. Clin Cancer Res. 2008;14:5484-5493.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 5484-5493
-
-
Xiong, Z.1
Gharagozlou, S.2
Vengco, I.3
-
12
-
-
34347232370
-
Intracellular cytokine optimization and standard operating procedure
-
Lamoreaux L, Roederer M, Koup R. Intracellular cytokine optimization and standard operating procedure. Nat Protoc. 2006;1:1507-1516.
-
(2006)
Nat Protoc
, vol.1
, pp. 1507-1516
-
-
Lamoreaux, L.1
Roederer, M.2
Koup, R.3
-
13
-
-
3042539632
-
Pharmacokinetics and safety of imiquimod 5% cream in the treatment of actinic keratoses of the face, scalp, or hands and arms
-
Harrison LI, Skinner SL, Marbury TC, et al. Pharmacokinetics and safety of imiquimod 5% cream in the treatment of actinic keratoses of the face, scalp, or hands and arms. Arch Dermatol Res. 2004;296:6-11. (Pubitemid 38828417)
-
(2004)
Archives of Dermatological Research
, vol.296
, Issue.1
, pp. 6-11
-
-
Harrison, L.I.1
Skinner, S.L.2
Marbury, T.C.3
Owens, M.L.4
Kurup, S.5
McKane, S.6
Greene, R.J.7
-
14
-
-
37349114848
-
In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma
-
DOI 10.1097/CJI.0b013e318155a0f6, PII 0000237120071100000001
-
Wu A, Oh S, Gharagozlou S, et al. In vivo vaccination with tumor cell lysate plus CpG oligodeoxynucleotides eradicates murine glioblastoma. J Immunother. 2007;30:789-797. (Pubitemid 350295357)
-
(2007)
Journal of Immunotherapy
, vol.30
, Issue.8
, pp. 789-797
-
-
Wu, A.1
Oh, S.2
Gharagozlou, S.3
Vedi, R.N.4
Ericson, K.5
Low, W.C.6
Chen, W.7
Ohlfest, J.R.8
-
15
-
-
33947574347
-
The antitumoral mode of action of imiquimod and other imidazoquinolines
-
DOI 10.2174/092986707780059625
-
Schon M, Schon MP. The antitumoral mode of action of imiquimod and other imidazoquinolines. Curr Med Chem. 2007;14:681-687. (Pubitemid 46477720)
-
(2007)
Current Medicinal Chemistry
, vol.14
, Issue.6
, pp. 681-687
-
-
Schon, M.1
Schon, M.P.2
-
16
-
-
33644770260
-
Adenosine receptors as therapeutic targets
-
DOI 10.1038/nrd1983, PII N1983
-
Jacobson KA, Gao ZG. Adenosine receptors as therapeutic targets. Nat Rev Drug Discov. 2006;5:247-264. (Pubitemid 43336037)
-
(2006)
Nature Reviews Drug Discovery
, vol.5
, Issue.3
, pp. 247-264
-
-
Jacobson, K.A.1
Gao, Z.-G.2
|